Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Matinas BioPharma Holdings Inc (MTNB)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Matinas BioPharma's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.1824 -0.0002    -0.11%
20:59:18 - Real-time Cboe. Currency in USD ( Disclaimer )
  • Volume: 788,378
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 0.1750 - 0.1868
Type:  Equity
Market:  United States
Matinas BioPharma 0.1824 -0.0002 -0.11%

MTNB User Rankings

 
This table ranks investing.com users according to the performance of their sentiments for Matinas BioPharma share prices.

Sign up for a free investing account and share your sentiments to see yourself on our Matinas BioPharma Holdings Inc sentiment user ranking table.
RankUsernameTotalClosedWinningWin %Chg. %
1Diego Martinez111100+400%
2Lauren Simon111100+290.41%
3Jonathan Barreto22150+253.4%
4pablo trader111100+220.22%
5Erich Acebedo111100+211.48%
6Wijnand Dors111100+185%
7Thierry Jacobsoone111100+131.52%
8Rogelio Jaralba111100+106.52%
9james dean111100+105.35%
10Niko Brouwer66350+99.6%
11David Ballard1000+64.1%
12Joaquin Domingues1000+64.1%
13Vishal Prasad32150+57.95%
14Luca Simioni1000+47.69%
15Young Kim111100+39.72%
16davide garulli111100+39.24%
17Maryia Alovic111100+36.37%
18Marc Vrijken111100+28.4%
19Vittorio Trojan111100+26.19%
20Ciaran Flah111100+25.96%
21Spencer Mulligan111100+21.21%
22Hermann Albrecht111100+14.86%
23Ben Rickert111100+6.4%
24Iván Rueda Pérez111100+6.1%
25Giacomo Garaud1100-1.97%
26Omar Daher Omar1100-14.96%
27Esteban CL1100-40.97%
28Angel Fernandez1100-265.38%
29Pascal Be1100-547.73%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MTNB Price Commentary

Write your thoughts about Matinas BioPharma Holdings Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Nick Thorp
Nick Thorp Oct 16, 2020 8:54
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Thier MAT9001 treatment for Severe Hypertriglyceridemia (SHTG) has successfully moved to Phase III trials and their LNC Lipid Nano Crystal drug delivery tech is a winner for licensing to other pharma co's looking for effective non toxic delivery of drugs/medications delivery program
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email